中国经济网北京2月22日讯 广济药业(000952.SZ)近日发布2026年向特定对象发行A股股票预案。公司本次发行拟 募集资金总额不超过60,000.00万元（含本数），扣除发行费用后用于偿还借款和补充流动资金。 本次向特定对象发行股票的发行对象为长江产业集团，拟以现金方式全额认购公司本次向特定对象发行的股 票。 本次向特定对象发行股票的定价基准日为第十一届董事会第十五次（临时）会议公告日。本次发行的发行价格 为6.32元/股，不低于定价基准日前二十个交易日公司股票交易均价的80%（定价基准日前二十个交易日股票交易均 价=定价基准日前二十个交易日股票交易总额/定价基准日前二十个交易日股票交易总量）。 本次发行股票数量不超过94,936,708股（含本数），不超过本次发行前公司总股本的30%，最终发行数量将在本 次发行通过深交所审核并经中国证监会同意注册后，按照相关规定，由上市公司股东会授权董事会根据中国证监会 相关规定及实际认购情况与保荐机构（主承销商）协商确定。 本次向特定对象发行的股票种类为人民币普通股（A股），每股面值为人民币1.00元。本次发行采取向特定对象 发行的方式。公司将在深交所审核通过并取得 ...

（文章来源：新京报） 新京报讯（记者刘旭）2月11日，湖北广济药业股份有限公司（简称"广济药业"）发布2026年向特定对 象发行A股股票预案，公司拟向控股股东长江产业集团发行股票募资不超过6亿元，扣除发行费用后将 全部用于偿还借款及补充流动资金。本次发行价格为6.32元/股。 广济药业表示，截至2025年9月30日，公司的资产负债率为62.67%，公司目前较高的资产负债率加大了 公司债务融资的成本，本次发行有利于公司优化资本结构，提高抗风险能力。同时，有利于稳固公司股 权结构，提升公司控制权稳定性；也有利于向社会公众传递积极信息，提升公司投资价值。 2025年10月以来，广济药业董事会曾四次审议通过向银行申请综合授信额度的议案，目的均为实现业务 发展和正常经营所需，包括：向中国民生银行股份有限公司武汉分行申请综合授信1.5亿元，授信期限1 年（其中中长期流动资金贷款支用额度不超过1亿元，期限不超过2年），担保方式为抵押，年利率不超 过3%；向华夏银行黄冈分行申请1.25亿元综合授信，其中1亿元可用于短期流动资金贷款，年利率不超 过2.98%，或开具1.25亿元银行承兑汇票，无抵押担保，资金用途包括采购原材料、 ...

Core Viewpoint - Guangji Pharmaceutical (000952) plans to raise up to 600 million yuan through a private placement to its controlling shareholder, Changjiang Industrial Group, at a price of 6.32 yuan per share, aimed at optimizing its capital structure and addressing financial pressures [1] Group 1: Fundraising and Financial Strategy - The funds raised will be used to repay loans and supplement working capital, with the company's debt-to-asset ratio standing at 62.67% as of September 30, 2025 [1] - The controlling shareholder's stake will increase from 25.26% to 41.33%, indicating strong support for the company [1] Group 2: Performance Forecast - The company anticipates a net loss of between 399 million yuan and 518 million yuan for 2025, marking the third consecutive year of losses, following losses of 140 million yuan in 2023 and 295 million yuan in 2024 [1] - Revenue has declined for two consecutive years, with 2024 revenue reported at 639 million yuan, a year-on-year decrease of 13.42% [3] Group 3: Recent Developments - On February 13, 2026, the company announced the receipt of a drug registration certificate for Mecobalamin tablets, which are used for the treatment of peripheral neuropathy [1] - The company also faces potential shareholder compensation risks due to possible information disclosure issues [1] Group 4: Market Performance - Over the past week (February 9 to 13, 2026), Guangji Pharmaceutical's stock price has shown a slight upward trend, with a price increase of 1.64% and a trading range fluctuation of 5.29% [2] - On February 13, the stock closed at 8.07 yuan, up 1.51%, with a trading volume of 94.31 million yuan and a turnover rate of 3.35% [2] - Technical indicators suggest a weak bullish signal, with the stock touching the upper Bollinger Band at 8.33 yuan [2] Group 5: Institutional Insights - Overall institutional ratings are neutral, with no significant bullish or bearish views [4] - The fund holding ratio is only 0.04%, indicating low institutional interest and activity [4] - Market attention remains moderate, with no clear directional guidance from public sentiment regarding short-term events [4]

广济药业（000952）(000952.SZ)发布2026年向特定对象发行A股股票预案，本次向特定对象发行股票的 发行对象为公司控股股东长江产业集团，发行对象符合法律、法规的规定。本次发行的股票全部采用现 金方式认购。预计募集资金总额不超过6亿元(含本数)，扣除发行费用后用于偿还借款和补充流动资 金。 ...

智通财经APP讯，广济药业(000952.SZ)发布2026年向特定对象发行A股股票预案，本次向特定对象发行 股票的发行对象为公司控股股东长江产业集团，发行对象符合法律、法规的规定。本次发行的股票全部 采用现金方式认购。预计募集资金总额不超过6亿元(含本数)，扣除发行费用后用于偿还借款和补充流 动资金。 ...

格隆汇2月11日丨广济药业（维权）(000952.SZ)公布，拟定增募集资金总额不超过6亿元，扣除发行费 用后用于偿还借款和补充流动资金。本次向特定对象发行股票的发行对象为公司控股股东长江产业集 团，发行对象符合法律、法规的规定。本次发行的股票全部采用现金方式认购。 ...

每经头条（nbdtoutiao）——男子街头逃亡、剑客山间打斗……电影级中国视频大模型被称"地表最 强"，几十个提示字生成15秒视频可商业交付，影视股大涨！记者亲测 （记者 张明双） 每经AI快讯，广济药业2月11日晚间发布公告称，本次向特定对象发行股票相关事项已经公司第十一届 董事会第十五次（临时）会议审议通过。本次向特定对象发行股票的发行对象为公司控股股东长江产业 集团，发行对象符合法律、法规的规定。本次向特定对象发行股票数量按照募集资金总额除以最终发行 价格计算得出，数量不足1股的余数作舍去处理，即发行数量不超过约9494万股（含本数），不超过本 次发行前公司总股本的30%。发行价格为6.32元/股。本次发行拟募集不超过6亿元，扣除发行费用后， 用于偿还借款和补充流动资金。 ...

【导读】长飞先进正式完成超10亿元A+轮股权融资 第三代半导体赛道又有大消息。 安徽长飞先进半导体股份有限公司(以下简称长飞先进)2月6日宣布，正式完成超10亿元A+轮股权融资。 作为第三代半导体材料的典型代表，碳化硅凭借耐高温、耐高压、高频化、低损耗等材料优势，成为新 能源汽车、光伏发电、智能电网、轨道交通等领域的关键材料，并在全球能源转型和半导体技术升级中 占据重要的战略地位。 目前，通过芜湖与武汉两大生产基地的战略布局，长飞先进已形成年产能42万片的碳化硅晶圆生产能 力，规模位居国内前列。其中，芜湖基地晶圆产线已实现满产；武汉基地于2025年5月成功通线，各项 关键技术指标均达到国际领先水平，全面满足新能源汽车主驱芯片的可靠性及稳定批量量产要求。 长飞先进的控股股东目前为长飞光纤（601869）。此前，长飞先进于2023年完成超38亿元A轮融资，融 资规模创国内第三代半导体私募股权融资规模之最，投资方包括光谷金控、中金资本等。 本轮融资由江城基金、长江产业集团领投，光谷金控、奇瑞旗下芯车智联基金等机构参投，融资资金将 主要用于碳化硅功率半导体全产业链技术布局，加速抢占新兴领域全球市场。 江城基金是由武汉 ...

Core Viewpoint - Changjiang Industrial Group successfully issued the first technology innovation corporate bond in Hubei Province for 2026, marking a significant milestone in the region's financial landscape [1] Group 1: Bond Issuance Details - The bond has a face interest rate of 1.90%, setting a record for the lowest rate for bonds of the same maturity issued nationwide this year [1] - The total issuance size of the bond is 1.865 billion yuan, making it the largest credit bond issued by Changjiang Industrial Group since 2016 [1] - The bond has a maturity period of 5 years and received a subscription multiple of 3.5 times [1] Group 2: Fund Utilization - Over 70% of the raised funds will be specifically used to replace equity in technology innovation sectors and fund contributions [1] - The key technology innovation areas covered include high-end equipment manufacturing, new energy, semiconductors, biomedicine, new materials, and next-generation information technology [1] Group 3: Market Impact and Future Plans - This bond issuance is the second market-making bond successfully issued by the group on the Shanghai Stock Exchange, attracting numerous investors and effectively reducing issuance costs [1] - Changjiang Industrial Group plans to continue focusing on technology innovation and industrial development needs to contribute to the high-quality development of Hubei's technology innovation industry [1]

Core Viewpoint - Government investment funds have become a major source of capital in China's equity investment industry, playing a crucial role in promoting healthy industry development and optimizing traditional industries [1][12]. Group 1: Policy and Regulatory Changes - The State Council issued the "Guiding Opinions on Promoting the High-Quality Development of Government Investment Funds" on January 7, 2025, outlining 25 measures across seven areas to enhance the fund management process [1][12]. - Local governments are increasingly focusing on optimizing existing government investment funds rather than solely establishing new ones, leading to a more pragmatic approach in fund creation [12][22]. - The "1号文" emphasizes that government investment funds should not be established solely for attracting investment, leading to a slowdown in new fund establishments, particularly in less economically robust regions [13][27]. Group 2: Fund Establishment and Trends - In the first half of 2025, 60 new government investment funds were established, surpassing the total of 55 in 2024, with a total scale of 188 billion yuan [6][8]. - The establishment of government investment funds is concentrated in economically vibrant regions like the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area, while interest in new funds has declined in the central and western regions [8][12]. - The trend is shifting towards a "fund cluster" model, focusing on multiple smaller funds with clear positioning rather than a few large-scale funds [26]. Group 3: Investment Focus and Strategies - Government investment funds are increasingly targeting strategic emerging industries such as new-generation information technology, biotechnology, and new energy vehicles, which are crucial for developing new productive forces [8][9]. - There is a consensus on "investing early and investing small," with both national and local funds showing more support for early-stage projects [9][10]. - The investment strategies of industry investment funds differ from venture capital funds, with a notable trend towards the mother-child fund structure to attract social capital [9][10]. Group 4: Management and Operational Efficiency - Most government investment funds have established sound systems and standardized operational processes, with many implementing ESG/responsible investment strategies [10][31]. - The management fee structures are becoming more refined and market-oriented, with a focus on cost control and performance [32][36]. - The introduction of a "tolerance for losses" policy allows for higher risk-taking, with some regions permitting up to 100% loss on individual projects [36][38]. Group 5: Exit Strategies and Market Dynamics - The recovery of the A-share and Hong Kong IPO markets in 2025 has provided a favorable environment for government investment funds to realize exits [41][42]. - The development of S funds and active mergers and acquisitions (M&A) markets are creating diversified exit channels for government investment funds [41][45]. - In 2025, the number of M&A transactions increased by 12.58%, indicating a more active market, with local governments becoming significant participants in M&A activities [48][49].